Updated Jul 16, 2026
Pangali Sanam has filed 1 SEC Form 4 filing across 1 company in the last 90 days — selling. Lifetime open-market sales: $140K.
Sanam Pangali is the Chief Legal Officer at Alumis Inc., a clinical-stage biopharmaceutical company focused on developing transformative medicines for autoimmune disorders. She has been involved in the company through various SEC filings.
| Role | Insider |
|---|---|
| Notability | 20/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-07-08 | ALMS | ALUMIS INC. | S — Open-market sale | 5.0K | $28.00 | $140K |
| 2026-07-08 | ALMS | ALUMIS INC. | M — Option exercise | 5.0K | $5.06 | $25K |
| 2025-07-29 | ALMS | ALUMIS INC. | A — Grant or award | 10.0K | $0.00 |
Sanam Pangali is the Chief Legal Officer at Alumis Inc., a clinical-stage biopharmaceutical company focused on developing transformative medicines for autoimmune disorders. She has been involved in the company through various SEC filings.…
1 primary Form 4 filings in the last 90 days, covering 1 company.
Recorded transactions: 0 open-market purchases () and 1 open-market sales ($140K) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Pangali Sanam profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.